Bosentas FC (62.5 mg) is an endothelin receptor antagonist, prescribed for pulmonary atrial hypertension (high blood pressure in the lungs). The medication blocks the effects of endothelin-1 thereby decreases blood pressure in lungs. The medication also inhibits blood vessel thickening.
Bosentas FC (62.5 mg) Tablet
Generic : Bosentan
Search for Drugs/Medicines
Medindia currently has information on 3,116
generic drugs and 110,306
brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us (firstname.lastname@example.org
) if a drug is missing from our comprehensive drug price list.
Drug information on Bosentas FC (62.5 mg) (Bosentan) from Cipla Limited
Drug Name : Bosentan
Bosentan(Tracleer) generic Bosentas FC (62.5 mg) is an endothelin receptor antagonist, prescribed for pulmonary atrial hypertension (high blood pressure in the lungs). The medication blocks the effects of endothelin-1 thereby decreases blood pressure in lungs. The medication also inhibits blood vessel thickening.
More Info about Bosentan
Initial: The recommended dose is 62.5 mg twice daily for 4 weeks. Maintenance dose is 125 mg twice daily.
Most Common: Respiratory tract infection, nausea, stomach pain, loss of appetite, chest pain, fainting, low blood pressure, palpitation and anemia.
Central Nervous System : Headache, dizziness and tiredness.
Genitourinary : Reduced sperm count.
Miscellaneous: Liver failure, rash, jaundice and joint pain.
It comes as a tablet to take by mouth, with or without food.
Contraindicated in pregnant women, co-administration with cyclosporine A and glyburide may increase the risk of liver damage; hypersensitivity.
Caution should be exercised in patients with history of heart disease, liver disease and anemia.
It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
During the treatment monitor the level of hemoglobin regularly.
Avoid pregnancy while taking this medication by using proper birth control methods.
♦Patient may develop oligohidrosis(absence of sweating) or high body temperature. If it is so consult with your healthcare provider.
Avoid alcoholic beverages.
Store it at room temperature (20ºC – 25ºC), and in an airtight container.
♦ Safety Labeling Changes Approved By FDA